12:00 AM
 | 
Aug 28, 2000
 |  BC Week In Review  |  Company News  |  Deals

Nova Molecular Inc., SignalGene deal

SGI will acquire Nova, a pharmacogenomics company, through the issue of 3.4 million SGI shares worth C$6.9 million ($4.6 million). Nova...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >